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Rural/Urban Disparities in Pneumococcal Vaccine Service Delivery Among  
the Fee-for-Service Medicare Population 
Jeffery Talbert, PhD; Aric Schadler, MS; and Patricia Freeman, RPh, PhD 
Overview of Key Findings 
▪ In 2014, the overall mean vaccination rate in urban areas was 4.66 compared to a mean vaccination 
rate of 2.81 in rural areas, indicating a 40% lower mean vaccination rate in rural communities. 
▪ The majority of pneumococcal vaccine services delivered to fee-for-service Medicare beneficiaries 
were provided by primary care providers, although pharmacy providers delivered close to one-fourth 
(22.2%) of these services. 
▪ The proportion of pneumococcal vaccine services delivered by pharmacy providers was significantly 
greater in rural versus urban counties (29.4% vs. 21.1%). 
▪ Consistent with previous literature, county characteristics positively associated with pneumococcal 
vaccine service delivery include increasing age of residents, more female residents, and availability of 
inpatient hospital services, while rurality, poverty, and greater overall health status were negatively 
associated with delivery of pneumococcal vaccine services. 
 
Introduction  
Community-acquired pneumonia (CAP) poses a considerable threat to the health of older adults, with the 
incidence of CAP increasing dramatically among those age 65 years and older.1 Streptococcus pneumoniae 
(pneumococcus) is a leading infectious cause of CAP although the organism also commonly causes other 
invasive diseases such as bacteremia and meningitis.  Mortality for invasive pneumococcal disease also 
increases with age, doubling from age 65 (20%) to age 85 (40%).1 Estimates suggest that pneumococci cause 
36% of adult CAP and 50% of all cases of bacterial meningitis in the US.1,2  
The morbidity and mortality associated with pneumococcal disease has led to recommendations that all persons 
age 65 and older be vaccinated.  Since 1997, CDC recommendations have called for all individuals in this age 
group to receive a single dose of the 23-valent pneumococcal polysaccharide vaccine (PPS23).  However, in 
August 2014, the Advisory Committee on Immunization Practices (ACIP) updated its recommendations to 
include routine use of 13-valent pneumococcal conjugate vaccine (PCV13), in addition to PPS23, in adults age 
65 years and older.  The ACIP recommendations were subsequently adopted by the CDC in September 2014.  
Even with the available vaccines and CDC guidelines supporting vaccination, there remains a significant 
portion of the population who qualify for these immunizations that have not been vaccinated.  Studies suggest 
that less than two-thirds of adults age 65 years and older have been vaccinated against pneumococcal disease,3,4 
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well short of the Department of Health and Human Services’ Healthy People 2020 national health target of 
90% for pneumococcal immunization coverage in this population.5 
Several factors can contribute to poor pneumococcal vaccine uptake in adults including inadequate knowledge 
and understanding of the need for vaccines, concerns over vaccine adverse effects, lack of provider 
recommendation, and negative provider attitudes towards the vaccine.6   
Geographic location can also factor into whether people are likely to get vaccinated.  Prior research has shown 
that people who live in rural areas generally have poorer health than people who live in urban areas.7 In 
addition, reduced access to clinic-based health care providers means rural residents may be less likely to 
receive adequate medical consultation and vaccination.8,9  To improve vaccine coverage overall, use of alternate 
sites for vaccine delivery has been recommended.9  Considering that currently all 50 states and D.C. authorize 
pharmacists to provide pneumococcal vaccines,10 and 93% of Americans live within 5 miles of a community 
pharmacy,11 vaccine administration in this alternate site may play a significant role in vaccine access, 
especially in rural communities. 
The objective of this study was to identify rural versus urban disparities in pneumococcal vaccine provision in 
the elderly (age 65 or older) adult population and assess the impact of pharmacy as an alternate site provider in 
rural communities. 
Methods 
The Medicare Physician and Other Supplier Public Use File (PUF) provides information on services and 
procedures provided to fee-for-service Medicare beneficiaries by physicians and other health care providers 
(including pharmacies and nurse practitioners).12 The PUF data contain information on utilization, payment, 
and charges by National Provider Identifier (NPI), Healthcare Common Procedure Coding System (HCPCS) 
code, and provider type for all providers delivering services to fee-for-service (FFS) Medicare beneficiaries.  
The 2014 Medicare provider data were extracted and merged with additional data on Medicare eligibility and 
characteristics for each county in the U.S.  Descriptive statistics were calculated and regression models were 
used to identify county-level factors associated with receipt of immunization.  To identify pneumococcal 
vaccination, HCPCS code G0009 was used for each provider billing Medicare.  We grouped providers into 
three categories:  1) primary care providers (e.g., family practice, internal medicine, and advanced practice 
registered nurses, regardless of practice location), 2) pharmacy providers, and 3) all other providers (physician 
specialties other than those listed as primary care providers).  The Rural-Urban Continuum Codes (RUCCs) 
were used to assign counties to rural versus urban designations, with codes 1-3 designated as urban and codes 
4-9 designated as rural.13 All provider services were aggregated at the county level and merged with additional 
data about the county (i.e., demographic characteristics, Medicare member characteristics). 
Findings 
In 2014, FFS Medicare 
providers delivered 
pneumococcal vaccine 
services to 1,444,829 
Medicare recipients, for a 
mean vaccination rate 
nationwide of 4.26.  
Pneumococcal vaccination 
services were delivered by 
Table 1.  Pneumococcal Vaccine Services by FFS Medicare 
Provider Type and Rural-Urban Designation, 2014 
Provider 
Type 
Rural             
 Frequency (%) 
Urban               
Frequency (%) Total 
Pharmacy    61,006 (29.4%) 260,809 (21.1%)    321,815 (22.2%) 
Primary Care 138,004 (66.4%) 908,991 (73.5%) 1,046,995 (72.5%) 
Other    8,693 (4.2%)  67,326 (5.4%)        76,019 (5.3%) 
Total 207,703 (14.4%) 1,237,126 (85.6%)   1,444,829 
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providers in 2,290 (72.9%) of 3,142 U.S. counties, although vaccines were available in 2,805 (89.3%) U.S. 
counties based on claims documenting the delivery of annual influenza vaccination services in those counties.  
Table 1 presents information on the number of pneumococcal vaccine services delivered by provider type in 
rural and urban counties. A significant disparity is noted between rural and urban vaccine service delivery with 
fewer vaccines administered in rural areas.  Of the 1,444,829 vaccination services provided in 2014, 207,703 
(14.4%) were delivered in rural areas compared to 1,237,126 (85.6%) delivered in urban areas.  The overall 
mean vaccination rate in urban areas was 4.66 compared to a mean vaccination rate of 2.81 in rural areas, 
indicating a 40% lower mean vaccination rate in rural communities. While these rates are low, we expect the 
cumulative rate to increase over the next few years as the recommendations for PCV13 administration, which 
were released in late 2014, are added to the standard of care. 
State-level rates of pneumococcal vaccine service delivery in the FFS Medicare population are depicted in 
Figure 1.  Considerable variation in rates is observed from a high of 6.3% in Colorado to a low of 1.1% in 
Maine. Visualization maps depicting pneumococcal vaccine service delivery rates at the county level, along 
with proportion of pneumococcal vaccine services delivered by provider type in rural and urban areas, are 
accessible on our website at https://ruhrc.uky.edu/infographics/. 
Figure 1.  Rate of Pneumococcal Vaccine Service Delivery per Eligible Population, 2014 
 
 
One important consideration in understanding and addressing vaccine service delivery disparities is the 
provider type associated with vaccine delivery in rural and urban areas. In 2014, over two-thirds (72.5%) of 
pneumococcal vaccine services were delivered to Medicare recipients by primary care providers, while 
pharmacy providers accounted for almost one-fourth (22.2%) of all pneumococcal vaccine services provided.  
A significantly greater proportion of pneumococcal vaccine services were delivered by pharmacy providers in 
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rural versus urban counties (29.4% vs. 21.1%), suggesting a possible role for pharmacy providers in 
minimizing vaccine service disparities between rural and urban areas. 
In addition to the descriptive results, we calculated multivariate regression models to identify county-level 
characteristics associated with receipt of pneumococcal vaccine.  Results indicate that increasing age of 
residents, greater proportion of female residents, and availability of inpatient hospital services were positively 
associated with pneumococcal vaccine services, while rurality, poverty, and greater overall health status were 
negatively associated with delivery of pneumococcal vaccine services.  Importantly, when we examined the 
relationships between provider types and rural vs. urban locations, we found that rural pharmacies play a key 
role in increasing access to vaccinations for FFS Medicare patients.  At the national level, 29.4% of 
pneumococcal vaccines are performed in pharmacies in rural counties, compared to only 21.1% in urban 
counties.  In states with greater rural designations, significantly higher proportions of vaccines are provided in 
pharmacies compared to primary care settings.  For example, in rural counties in Idaho, almost three-fourths 
(74.3%) of pneumococcal vaccine services are provided in pharmacies compared to 40.4% of pneumococcal 
vaccines provided in pharmacies in urban counties. 
Conclusion/Discussion 
In 2014, a significant disparity in pneumococcal vaccine service delivery was noted between rural and urban 
areas across the nation, with a 60% lower vaccination rate observed in rural communities. Primary care 
providers delivered the majority of pneumococcal vaccine services to elderly adults in the FFS Medicare 
population, with pharmacy providers delivering almost a quarter of pneumococcal vaccine services.  This 
finding is consistent with a recent study, which showed that almost a quarter of U.S. adults who reported 
receiving an annual influenza vaccine indicated they received those services from a pharmacy-based store.14 A 
significantly greater proportion of pneumococcal vaccine services are delivered by pharmacy providers in rural 
areas compared to urban areas, and regression models indicate that pharmacy providers have a significant 
impact on pneumococcal vaccine delivery in rural areas.  Given that over 50% of the nation’s primary care 
health professional shortage is in rural areas, access to primary care providers may limit delivery of 
pneumococcal vaccination services in that setting, resulting in a shift to service delivery in pharmacies as 
shown in this study.  Rural pharmacies play a key role in access to pneumococcal vaccinations for Medicare 
patients.  Engaging community pharmacists who are already embedded in rural communities may help address 
the need for increasing rural populations’ access to health care and improving vaccination rates across all 
demographic sectors. 
 
References 
1. CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book), 13th ed. 
Washington, DC: Public Health Foundation; 2015. 
2. Jain S, Self WH, Wunderink RG, et al. Community-Acquired Pneumonia Requiring Hospitalization among 
U.S. Adults. N Engl J Med. 2015;373(5):415-427. 
3. Williams W, Lu P, O’Halloran A, et al. Surveillance of Vaccination Coverage Among Adult Populations, 
United States, 2015. Morbidity and Mortality Weekly Report (MMWR). 2017;66(11):1-28. 
4. CDC. Non-influenza Vaccination Coverage among Adults: United States, 2012. Morbidity and Mortality 
Weekly Report (MMWR). 2014;63(5):95-102. 
5. U.S. Department of Health and Human Services. HealthyPeople.gov. 2020 Topics & Objectives, 
Immunization and Infectious Diseases. Washington, DC: HHS. Available at: 
Disparities in Pneumococcal Vaccine Delivery  Policy Brief 
 
Rural & Underserved Health Research Center  Page 5 
https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases. 
Accessed August 11, 2017. 
6. Anderson E. Recommended Solutions to the Barriers to Immunization in Children and Adults. Mo Med. 
2014;111(4):344-348. 
7. Georgetown University, Health Policy Institute. Rural and Urban Health. Data Profile Number 7, January 
2003. Available at: https://hpi.georgetown.edu/agingsociety/pubhtml/rural/rural.html. Accessed August 6, 
2017.  
8. Jones TF, Amanda IL, Craig AS, Schaffner W. Determinants of Influenza Vaccination, 2003–2004: 
Shortages, Fallacies and Disparities. Clin Infect Dis. 2004; 39(12):1824-1828. 
9. Bennett KJ, Pumkam C, Probst JC. Rural-Urban Differences in the Location of Influenza Vaccine 
Administration. Vaccine. 2011;29(35):5970-5977.  
10. Schmit C, Reddick A. Pharmacist Vaccination Laws. The Policy Surveillance Program: A LawAtlas 
Project. Available at: http://lawatlas.org/datasets/pharmacist-vaccination. Accessed August 6, 2017. 
11. National Association of Chain Drug Stores. Chain Pharmacy Industry Profile 2011-2012. Arlington, VA: 
NACDS; 2012. 
12. Centers for Medicare & Medicaid Services. Medicare Provider Utilization and Payment Data: Physician 
and Other Supplier. Baltimore, MD: CMS. Available at: https://www.cms.gov/Research-Statistics-Data-
and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Physician-and-Other-
Supplier.html.  Accessed August 11, 2017. 
13. U.S. Department of Agriculture, Economic Research Service. Rural-Urban Continuum Codes. Washington, 
DC: USDA; 2013. Available at: https://www.ers.usda.gov/data-products/rural-urban-continuum-
codes/documentation.aspx.  Accessed August 11, 2017. 
14. Inguva S, Sautter JM, Chun GJ, Patterson BJ, McGhan WF. Population Characteristics Associated with 
Pharmacy-based Influenza Vaccination in U.S. Survey Data. J Am Pharm Assoc. July 28, 2017. DOI: 
http://dx.doi.org/10.1016/j.japh.2017.07.007 
 
Contact Information 
Jeff Talbert, Deputy Director, Rural and Underserved Health Research Center 
email: jeff.talbert@uky.edu  website:  http://ruhrc.uky.edu 
 
Suggested Citation 
Talbert J, Schadler A, Freeman P. Rural/Urban Disparities in Pneumococcal Vaccine Service Delivery Among  
the Fee-for-Service Medicare Population.  Lexington, KY:  Rural and Underserved Health Research Center; 2018. 
